Le syndrome des antiphospholipides en néphrologie. Atteinte rénale et aspects pratiques de la prise en charge

Le syndrome des antiphospholipides est une thrombophilie caractérisée par l’association d’un événement clinique thrombotique (artériel et/ou veineux) ou obstétrical, associé à la présence durable d’anticorps antiphospholipides. L’atteinte pouvant toucher l’ensemble de l’arbre vasculaire, une atteint...

Full description

Saved in:
Bibliographic Details
Published inNéphrologie & thérapeutique Vol. 10; no. 1; pp. 1 - 9
Main Authors Dekeyser, Manon, Zuily, Stéphane, Champigneulle, Jacqueline, Eschwège, Valérie, Frimat, Luc, Perret-Guillaume, Christine, Wahl, Denis
Format Journal Article
LanguageFrench
Published Issy-les-Moulineaux Elsevier SAS 01.02.2014
Elsevier Masson
Elsevier Masson (jusqu'en 2022) / John Libbey Eurotext (à partir de 2023)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Le syndrome des antiphospholipides est une thrombophilie caractérisée par l’association d’un événement clinique thrombotique (artériel et/ou veineux) ou obstétrical, associé à la présence durable d’anticorps antiphospholipides. L’atteinte pouvant toucher l’ensemble de l’arbre vasculaire, une atteinte rénale est fréquemment associée avec la description maintenant bien codifiée de la néphropathie associée au syndrome des antiphospholipides. Nous proposons dans cette revue des recommandations actualisées sur la prise en charge du syndrome des antiphospholipides en néphrologie. La thérapeutique se base sur une anticoagulation plus ou moins une antiagrégation à long terme en fonction des événements cliniques sans oublier le recours à une néphroprotection classique (contrôle strict de la pression artérielle avec notamment des thérapeutiques bloquant le système rénine–angiotensine–aldostérone). Le syndrome catastrophique des antiphospholipides est une complication extrêmement grave pouvant mettre en jeu le pronostic vital du patient. Celui-ci justifie une attention toute particulière, ainsi qu’une prévention dans les situations à risque. Nous illustrons également les difficultés de prise en charge au long cours de ces patients, tant en dialyse qu’en transplantation rénale. The antiphospholipid syndrome is a thrombophilia characterized by the combination of arterial and/or venous thrombotic events or obstetric clinical events, associated with persistent presence of antiphospholipid antibodies. In this syndrome, thromboses may affect all of the vascular tree, renal damage is frequently associated with a specific antiphospholipid syndrome nephropathy. We propose in this review to provide updated recommendations on the management of antiphospholipid syndrome in nephrology. Treatment is based on long-term anticoagulant therapy with or without antiplatelet agents according to clinical events. The use of a conventional nephroprotection must not be forgotten (strict control of blood pressure with drugs blocking the renin–angiotensin–aldosterone system). Catastrophic antiphospholipid syndrome is an extremely severe complication which can threaten the vital prognosis of the patient. This justifies particular surveillance, as well as prevention in high-risk situations. We also illustrate the difficulties of long-term management in these patients, both in dialysis or kidney transplantation.
AbstractList Le syndrome des antiphospholipides est une thrombophilie caractérisée par l’association d’un événement clinique thrombotique (artériel et/ou veineux) ou obstétrical, associé à la présence durable d’anticorps antiphospholipides. L’atteinte pouvant toucher l’ensemble de l’arbre vasculaire, une atteinte rénale est fréquemment associée avec la description maintenant bien codifiée de la néphropathie associée au syndrome des antiphospholipides. Nous proposons dans cette revue des recommandations actualisées sur la prise en charge du syndrome des antiphospholipides en néphrologie. La thérapeutique se base sur une anticoagulation plus ou moins une antiagrégation à long terme en fonction des événements cliniques sans oublier le recours à une néphroprotection classique (contrôle strict de la pression artérielle avec notamment des thérapeutiques bloquant le système rénine–angiotensine–aldostérone). Le syndrome catastrophique des antiphospholipides est une complication extrêmement grave pouvant mettre en jeu le pronostic vital du patient. Celui-ci justifie une attention toute particulière, ainsi qu’une prévention dans les situations à risque. Nous illustrons également les difficultés de prise en charge au long cours de ces patients, tant en dialyse qu’en transplantation rénale. The antiphospholipid syndrome is a thrombophilia characterized by the combination of arterial and/or venous thrombotic events or obstetric clinical events, associated with persistent presence of antiphospholipid antibodies. In this syndrome, thromboses may affect all of the vascular tree, renal damage is frequently associated with a specific antiphospholipid syndrome nephropathy. We propose in this review to provide updated recommendations on the management of antiphospholipid syndrome in nephrology. Treatment is based on long-term anticoagulant therapy with or without antiplatelet agents according to clinical events. The use of a conventional nephroprotection must not be forgotten (strict control of blood pressure with drugs blocking the renin–angiotensin–aldosterone system). Catastrophic antiphospholipid syndrome is an extremely severe complication which can threaten the vital prognosis of the patient. This justifies particular surveillance, as well as prevention in high-risk situations. We also illustrate the difficulties of long-term management in these patients, both in dialysis or kidney transplantation.
The antiphospholipid syndrome is a thrombophilia characterized by the combination of arterial and/or venous thrombotic events or obstetric clinical events, associated with persistent presence of antiphospholipid antibodies. In this syndrome, thromboses may affect all of the vascular tree, renal damage is frequently associated with a specific antiphospholipid syndrome nephropathy. We propose in this review to provide updated recommendations on the management of antiphospholipid syndrome in nephrology. Treatment is based on long-term anticoagulant therapy with or without antiplatelet agents according to clinical events. The use of a conventional nephroprotection must not be forgotten (strict control of blood pressure with drugs blocking the renin-angiotensin-aldosterone system). Catastrophic antiphospholipid syndrome is an extremely severe complication which can threaten the vital prognosis of the patient. This justifies particular surveillance, as well as prevention in high-risk situations. We also illustrate the difficulties of long-term management in these patients, both in dialysis or kidney transplantation. Le syndrome des antiphospholipides est une thrombophilie caractérisée par l’association d’un événement clinique thrombotique (artériel et/ou veineux) ou obstétrical, associé à la présence durable d’anticorps antiphospholipides. L’atteinte pouvant toucher l’ensemble de l’arbre vasculaire, une atteinte rénale est fréquemment associée avec la description maintenant bien codifiée de la néphropathie associée au syndrome des antiphospholipides. Nous proposons dans cette revue des recommandations actualisées sur la prise en charge du syndrome des antiphospholipides en néphrologie. La thérapeutique se base sur une anticoagulation plus ou moins une antiagrégation à long terme en fonction des événements cliniques sans oublier le recours à une néphroprotection classique (contrôle strict de la pression artérielle avec notamment des thérapeutiques bloquant le système rénine–angiotensine–aldostérone). Le syndrome catastrophique des antiphospholipides est une complication extrêmement grave pouvant mettre en jeu le pronostic vital du patient. Celui-ci justifie une attention toute particulière, ainsi qu’une prévention dans les situations à risque. Nous illustrons également les difficultés de prise en charge au long cours de ces patients, tant en dialyse qu’en transplantation rénale.
Author Champigneulle, Jacqueline
Dekeyser, Manon
Wahl, Denis
Zuily, Stéphane
Frimat, Luc
Eschwège, Valérie
Perret-Guillaume, Christine
Author_xml – sequence: 1
  givenname: Manon
  surname: Dekeyser
  fullname: Dekeyser, Manon
  email: manondekeyser@gmail.com
  organization: Service de néphrologie-hémodialyse-transplantation, CHU de Nancy, rue du Morvan, 54511 Vandœuvre-lès-Nancy, France
– sequence: 2
  givenname: Stéphane
  surname: Zuily
  fullname: Zuily, Stéphane
  organization: Service de médecine vasculaire, centre de compétence régional des maladies vasculaires rares et systémiques et auto-immunes, institut lorrain du cœur et des vaisseaux Louis-Mathieu, CHU de Nancy, rue du Morvan, 54511 Vandœuvre-lès-Nancy, France
– sequence: 3
  givenname: Jacqueline
  surname: Champigneulle
  fullname: Champigneulle, Jacqueline
  organization: Laboratoire d’anatomopathologie, CHU de Nancy, rue du Morvan, 54511 Vandœuvre-lès-Nancy, France
– sequence: 4
  givenname: Valérie
  surname: Eschwège
  fullname: Eschwège, Valérie
  organization: Laboratoire d’hématologie biologique, CHU de Nancy, rue du Morvan, 54511 Vandœuvre-lès-Nancy, France
– sequence: 5
  givenname: Luc
  surname: Frimat
  fullname: Frimat, Luc
  organization: Service de néphrologie-hémodialyse-transplantation, CHU de Nancy, rue du Morvan, 54511 Vandœuvre-lès-Nancy, France
– sequence: 6
  givenname: Christine
  surname: Perret-Guillaume
  fullname: Perret-Guillaume, Christine
  organization: Pôle de gérontologie-soins palliatifs, CHU de Nancy, rue du Morvan, 54511 Vandœuvre-lès-Nancy, France
– sequence: 7
  givenname: Denis
  surname: Wahl
  fullname: Wahl, Denis
  organization: Service de médecine vasculaire, centre de compétence régional des maladies vasculaires rares et systémiques et auto-immunes, institut lorrain du cœur et des vaisseaux Louis-Mathieu, CHU de Nancy, rue du Morvan, 54511 Vandœuvre-lès-Nancy, France
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28130788$$DView record in Pascal Francis
https://hal.univ-lorraine.fr/hal-01791299$$DView record in HAL
BookMark eNp9kM1u3CAQx1GVqPlo36AHLj30YJcB1sCl0ipqPqSVeknPiMXjLCsHXHAj5ZHyHHmxYjnKsQc0zPD_zzC_C3ISU0RCvgBrgUH3_dhGnA45tZyBaJlqRac_kHPQijcGlDqpd9WZRvHN5oxclHJkTGgJ8JGc8RoEGH1O0g5peY59To9IeyzUxTlMh1TqGcMUlhJGGl9fllljegjY0u08Y4gz0vz6Et2IFGfqyoR-LnTKbg5__lZbj3R0NQ8Flxb-4PIDfiKngxsLfn6Ll-T39c_7q9tm9-vm7mq7azx0UjdccgV-rxgbpHJOy8GBQCcEdnU3pzsuNxI3noHx3EuzN9rjXhlZH0znvbgk39a-Bzfa-odHl59tcsHebnd2qTFQBrgxT1C1ctX6nErJOLwbgNmFtT3albVdWFumbGVdbV9X2-SKd-OQXfShvHu5BsGUXnQ_Vh3WfZ8CZlt8wOixD7kis30K_x_0D6urmEQ
Cites_doi 10.1016/j.revmed.2012.01.005
10.1681/ASN.V13142
10.1191/0961203303lu394oa
10.1136/ard.2008.096669
10.1111/j.1600-6143.2010.03233.x
10.1111/j.1538-7836.2006.01753.x
10.1016/j.transproceed.2004.12.151
10.1016/0272-6386(95)90656-8
10.2215/CJN.00460110
10.1177/0961203307084724
10.1016/j.nephro.2011.12.005
10.1681/ASN.2007030257
10.1182/blood.V98.6.1760
10.1002/art.10187
10.1046/j.1523-1755.2002.00500.x
10.1002/art.22663
10.1093/ndt/gfq356
10.1681/ASN.V103507
10.1016/j.revmed.2008.05.013
10.1038/ki.1995.352
10.1046/j.1523-1755.1999.00258.x
10.1182/blood-2011-03-340232
10.1159/000235941
10.1093/ndt/7.12.1194
10.1097/00041552-200103000-00004
10.1136/ard.2010.142042
10.1097/00007890-199901150-00015
10.1161/CIRCULATIONAHA.111.028522
10.1016/j.autrev.2010.08.005
10.1016/j.revmed.2012.01.007
10.1038/ki.2011.477
10.1177/0961203310395803
ContentType Journal Article
Copyright 2013 Association Société de néphrologie
2015 INIST-CNRS
Distributed under a Creative Commons Attribution 4.0 International License
Copyright_xml – notice: 2013 Association Société de néphrologie
– notice: 2015 INIST-CNRS
– notice: Distributed under a Creative Commons Attribution 4.0 International License
DBID IQODW
AAYXX
CITATION
1XC
DOI 10.1016/j.nephro.2013.07.368
DatabaseName Pascal-Francis
CrossRef
Hyper Article en Ligne (HAL)
DatabaseTitle CrossRef
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Antiphospholipid syndrome in nephrology. Kidney damage and practical aspects of the management
EISSN 1872-9177
EndPage 9
ExternalDocumentID oai_HAL_hal_01791299v1
10_1016_j_nephro_2013_07_368
28130788
S1769725513004963
GroupedDBID --K
--M
.~1
0R~
123
1B1
1~.
1~5
4.4
457
4G.
53G
5VS
7-5
71M
8P~
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAXUO
ABBQC
ABFNM
ABLJU
ABLVK
ABMAC
ABMZM
ABXDB
ABYKQ
ACDAQ
ACGFS
ACRLP
ADBBV
ADEZE
AEBSH
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
AXJTR
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FIRID
FNPLU
G-Q
GBLVA
HVGLF
HZ~
IHE
J1W
KOM
LCYCR
LN9
M41
MO0
N9A
O-L
O9-
OAUVE
OZT
P-8
P-9
PC.
Q38
RIG
ROL
RPZ
SDF
SDG
SEM
SES
SSH
SSZ
T5K
~G-
ABPIF
ADALY
FYGXN
IPNFZ
IQODW
AAYXX
AKRWK
CITATION
1XC
ID FETCH-LOGICAL-c1648-24271cb700f47aa84fa13ea33e6917a862454e5c019c2c49b98ceb79462496cc3
IEDL.DBID AIKHN
ISSN 1769-7255
IngestDate Thu Sep 19 06:33:07 EDT 2024
Fri Aug 23 02:23:18 EDT 2024
Thu Nov 24 18:27:05 EST 2022
Fri Feb 23 02:22:21 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Traitement
Treatment
Dialyse
Syndrome des antiphospholipides
Transplantation
Dialysis
Néphropathie associée au syndrome des antiphospholipides
Antiphospholipid syndrome
Antiphospholipid syndrome nephropathy
Immunopathologie
Pathologie de l'appareil circulatoire
Pathologie du rein
Pathologie de l'appareil urinaire
Pathologie des vaisseaux sanguins
Néphropathie
Lésion
Prise en charge
Hémopathie
Urologie
Greffe
Maladie autoimmune
Néphrologie
Chirurgie
Thrombocyte
Conduite à tenir
Rein
Appareil urinaire
Language French
License CC BY 4.0
Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c1648-24271cb700f47aa84fa13ea33e6917a862454e5c019c2c49b98ceb79462496cc3
ORCID 0000-0003-4846-6793
PMID 24113198
PageCount 9
ParticipantIDs hal_primary_oai_HAL_hal_01791299v1
crossref_primary_10_1016_j_nephro_2013_07_368
pascalfrancis_primary_28130788
elsevier_sciencedirect_doi_10_1016_j_nephro_2013_07_368
PublicationCentury 2000
PublicationDate 2014-02
PublicationDateYYYYMMDD 2014-02-01
PublicationDate_xml – month: 02
  year: 2014
  text: 2014-02
PublicationDecade 2010
PublicationPlace Issy-les-Moulineaux
PublicationPlace_xml – name: Issy-les-Moulineaux
PublicationTitle Néphrologie & thérapeutique
PublicationYear 2014
Publisher Elsevier SAS
Elsevier Masson
Elsevier Masson (jusqu'en 2022) / John Libbey Eurotext (à partir de 2023)
Publisher_xml – name: Elsevier SAS
– name: Elsevier Masson
– name: Elsevier Masson (jusqu'en 2022) / John Libbey Eurotext (à partir de 2023)
References Nzerue, Hewan-Lowe, Pierangeli, Harris (bib0010) 2002; 62
Saadoun, Piette, Wahl, Costedoat-Chalumeau (bib0110) 2012; 33
Serrano, García, Serrano, Ramírez, Alfaro, Lora (bib0165) 2012; 81
Sinico, Cavazzana, Nuzzo, Vianelli, Napodano, Scaini (bib0080) 2010; 5
Wahl, Perret-Guillaume, Piette (bib0125) 2008; 29
Ozmen, Danis, Akin, Batun (bib0170) 2009; 72
Pengo, Ruffatti, Legnani, Testa, Fierro, Marongiu (bib0025) 2011; 118
Erkan, Harrison, Levy, Peterson, Petri, Sammaritano (bib0105) 2007; 56
Daugas, Nochy, Huong, Duhaut, Beaufils, Caudwell (bib0090) 2002; 13
Roozbeh, Serati, Malekhoseini (bib0155) 2006; 9
Cervera, Piette, Font, Khamashta, Shoenfeld, Camps (bib0030) 2002; 46
Costedoat-Chalumeau, Arnaud, Saadoun, Chastre, Leroux, Cacoub (bib0060) 2012; 33
Bollée, Moulin, Martinez, Meulders, Rougier, Baumelou (bib0055) 2012; 8
Wahl, Saadi, Perret-Guillaume, Membre, Frederic, Devignes (bib0015) 2007; 13
Diz-Küçükkaya, Hacihanefioğlu, Yenerel, Turgut, Keskin, Nalçaci (bib0040) 2001; 98
Hereng, Lambert, Hachulla, Samor, Dubucquoi, Caron (bib0100) 2008; 17
Alchi, Griffiths, Jayne (bib0070) 2010; 25
Miyakis, Lockshin, Atsumi, Branch, Brey, Cervera (bib0005) 2006; 4
Gigante, Gasperini, Cianci, Barbano, Giannakakis, Di Donato (bib0130) 2009; 30
Canaud, Bienaimé, Noël, Royal, Alyanakian, Dautzenberg (bib0180) 2010; 10
Hill, Nochy (bib0095) 2007; 18
Prakash, Miller, Suki (bib0160) 1995; 26
Ducloux, Pellet, Fournier, Rebibou, Bresson-Vautrin, Racadot (bib0185) 1999; 67
Zuily, Regnault, Selton-Suty, Eschwège, Bruntz, Bode-Dotto (bib0035) 2011; 124
Daugas, Hachulla, Darnige (bib0075) 2012
Manns, Burgess, Parsons, Schaefer, Hyndman, Scott-Douglas (bib0150) 1999; 55
Brunet, Aillaud, San Marco, Philip-Joet, Dussol, Bernard (bib0145) 1995; 48
Vaidya (bib0175) 2005; 37
Ruiz-Irastorza, Cuadrado, Ruiz-Arruza, Brey, Crowther, Derksen (bib0020) 2011; 20
Ruffatti, Del Ross, Ciprian, Nuzzo, Rampudda, Bertero (bib0115) 2009; 68
Joseph, Radhakrishnan, Appel (bib0135) 2001; 10
Erkan, Espinosa, Cervera (bib0050) 2010; 10
Asherson, Cervera, de Groot, Erkan, Boffa, Piette (bib0045) 2003; 12
Ruffatti, Del Ross, Ciprian, Bertero, Sciascia, Salvatore (bib0120) 2011; 70
Chew, Lins, Daelemans, Zachee, De Clerck, Vermylen (bib0140) 1992; 7
Nochy, Daugas, Droz, Beaufils, Grünfeld, Piette (bib0085) 1999; 10
Erkan, Leibowitz, Berman, Lockshin (bib0065) 2002; 29
Ruffatti (10.1016/j.nephro.2013.07.368_bib0115) 2009; 68
Roozbeh (10.1016/j.nephro.2013.07.368_bib0155) 2006; 9
Vaidya (10.1016/j.nephro.2013.07.368_bib0175) 2005; 37
Erkan (10.1016/j.nephro.2013.07.368_bib0065) 2002; 29
Gigante (10.1016/j.nephro.2013.07.368_bib0130) 2009; 30
Nzerue (10.1016/j.nephro.2013.07.368_bib0010) 2002; 62
Joseph (10.1016/j.nephro.2013.07.368_bib0135) 2001; 10
Brunet (10.1016/j.nephro.2013.07.368_bib0145) 1995; 48
Asherson (10.1016/j.nephro.2013.07.368_bib0045) 2003; 12
Erkan (10.1016/j.nephro.2013.07.368_bib0105) 2007; 56
Wahl (10.1016/j.nephro.2013.07.368_bib0125) 2008; 29
Daugas (10.1016/j.nephro.2013.07.368_bib0090) 2002; 13
Ruffatti (10.1016/j.nephro.2013.07.368_bib0120) 2011; 70
Serrano (10.1016/j.nephro.2013.07.368_bib0165) 2012; 81
Miyakis (10.1016/j.nephro.2013.07.368_bib0005) 2006; 4
Wahl (10.1016/j.nephro.2013.07.368_bib0015) 2007; 13
Bollée (10.1016/j.nephro.2013.07.368_bib0055) 2012; 8
Cervera (10.1016/j.nephro.2013.07.368_bib0030) 2002; 46
Daugas (10.1016/j.nephro.2013.07.368_bib0075) 2012
Zuily (10.1016/j.nephro.2013.07.368_bib0035) 2011; 124
Saadoun (10.1016/j.nephro.2013.07.368_bib0110) 2012; 33
Diz-Küçükkaya (10.1016/j.nephro.2013.07.368_bib0040) 2001; 98
Nochy (10.1016/j.nephro.2013.07.368_bib0085) 1999; 10
Hill (10.1016/j.nephro.2013.07.368_bib0095) 2007; 18
Ducloux (10.1016/j.nephro.2013.07.368_bib0185) 1999; 67
Chew (10.1016/j.nephro.2013.07.368_bib0140) 1992; 7
Manns (10.1016/j.nephro.2013.07.368_bib0150) 1999; 55
Prakash (10.1016/j.nephro.2013.07.368_bib0160) 1995; 26
Erkan (10.1016/j.nephro.2013.07.368_bib0050) 2010; 10
Sinico (10.1016/j.nephro.2013.07.368_bib0080) 2010; 5
Ozmen (10.1016/j.nephro.2013.07.368_bib0170) 2009; 72
Costedoat-Chalumeau (10.1016/j.nephro.2013.07.368_bib0060) 2012; 33
Hereng (10.1016/j.nephro.2013.07.368_bib0100) 2008; 17
Canaud (10.1016/j.nephro.2013.07.368_bib0180) 2010; 10
Ruiz-Irastorza (10.1016/j.nephro.2013.07.368_bib0020) 2011; 20
Pengo (10.1016/j.nephro.2013.07.368_bib0025) 2011; 118
Alchi (10.1016/j.nephro.2013.07.368_bib0070) 2010; 25
References_xml – volume: 13
  start-page: 1
  year: 2007
  end-page: 11
  ident: bib0015
  article-title: Syndrome des antiphospholipides. Classification actuelle et indications thérapeutiques
  publication-title: Med Ther
  contributor:
    fullname: Devignes
– volume: 18
  start-page: 2461
  year: 2007
  end-page: 2464
  ident: bib0095
  article-title: Antiphospholipid syndrome in systemic lupus erythematosus
  publication-title: J Am Soc Nephrol
  contributor:
    fullname: Nochy
– volume: 9
  start-page: 26
  year: 2006
  end-page: 32
  ident: bib0155
  article-title: Arteriovenous fistula thrombosis in patients on regular hemodialysis: a report of 171 patients
  publication-title: Arch Iran Med
  contributor:
    fullname: Malekhoseini
– volume: 118
  start-page: 4714
  year: 2011
  end-page: 4718
  ident: bib0025
  article-title: Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study
  publication-title: Blood
  contributor:
    fullname: Marongiu
– volume: 37
  start-page: 650
  year: 2005
  end-page: 651
  ident: bib0175
  article-title: Management of end-stage renal disease patients with antiphospholipid antibody syndrome
  publication-title: Transplant Proc
  contributor:
    fullname: Vaidya
– volume: 10
  start-page: 2051
  year: 2010
  end-page: 2060
  ident: bib0180
  article-title: Severe vascular lesions and poor functional outcome in kidney transplant recipients with lupus anticoagulant antibodies
  publication-title: Am J Transplant
  contributor:
    fullname: Dautzenberg
– volume: 62
  start-page: 733
  year: 2002
  end-page: 744
  ident: bib0010
  article-title: “Black swan in the kidney”: renal involvement in the antiphospholipid antibody syndrome
  publication-title: Kidney Int
  contributor:
    fullname: Harris
– volume: 124
  start-page: 215
  year: 2011
  end-page: 224
  ident: bib0035
  article-title: Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies
  publication-title: Circulation
  contributor:
    fullname: Bode-Dotto
– volume: 13
  start-page: 42
  year: 2002
  end-page: 52
  ident: bib0090
  article-title: Antiphospholipid syndrome nephropathy in systemic lupus erythematosus
  publication-title: J Am Soc Nephrol
  contributor:
    fullname: Caudwell
– volume: 25
  start-page: 3147
  year: 2010
  end-page: 3154
  ident: bib0070
  article-title: What nephrologists need to know about antiphospholipid syndrome
  publication-title: Nephrol Dial Transplant
  contributor:
    fullname: Jayne
– volume: 5
  start-page: 1211
  year: 2010
  end-page: 1217
  ident: bib0080
  article-title: Renal involvement in primary antiphospholipid syndrome: retrospective analysis of 160 patients
  publication-title: Clin J Am Soc Nephrol
  contributor:
    fullname: Scaini
– volume: 7
  start-page: 1194
  year: 1992
  end-page: 1198
  ident: bib0140
  article-title: Are antiphospholipid antibodies clinically relevant in dialysis patients?
  publication-title: Nephrol Dial Transplant
  contributor:
    fullname: Vermylen
– volume: 55
  start-page: 315
  year: 1999
  end-page: 320
  ident: bib0150
  article-title: Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients
  publication-title: Kidney Int
  contributor:
    fullname: Scott-Douglas
– volume: 33
  start-page: 194
  year: 2012
  end-page: 199
  ident: bib0060
  article-title: Catastrophic antiphospholipid syndrome
  publication-title: Rev Med Interne
  contributor:
    fullname: Cacoub
– volume: 12
  start-page: 530
  year: 2003
  end-page: 534
  ident: bib0045
  article-title: Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines
  publication-title: Lupus
  contributor:
    fullname: Piette
– volume: 29
  start-page: 843
  year: 2002
  end-page: 849
  ident: bib0065
  article-title: Perioperative medical management of antiphospholipid syndrome: hospital for special surgery experience, review of literature, and recommendations
  publication-title: J Rheumatol
  contributor:
    fullname: Lockshin
– volume: 68
  start-page: 397
  year: 2009
  end-page: 399
  ident: bib0115
  article-title: Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study
  publication-title: Ann Rheum Dis
  contributor:
    fullname: Bertero
– volume: 10
  start-page: 507
  year: 1999
  end-page: 518
  ident: bib0085
  article-title: The intrarenal vascular lesions associated with primary antiphospholipid syndrome
  publication-title: J Am Soc Nephrol
  contributor:
    fullname: Piette
– volume: 30
  start-page: 405
  year: 2009
  end-page: 412
  ident: bib0130
  article-title: Antiphospholipid antibodies and renal involvement
  publication-title: Am J Nephrol
  contributor:
    fullname: Di Donato
– volume: 17
  start-page: 11
  year: 2008
  end-page: 15
  ident: bib0100
  article-title: Influence of aspirin on the clinical outcomes of 103 antiphospholipid antibodies-positive patients
  publication-title: Lupus
  contributor:
    fullname: Caron
– year: 2012
  ident: bib0075
  article-title: Atteintes rénales du syndrome des anticorps antiphospholipides
  contributor:
    fullname: Darnige
– volume: 26
  start-page: 347
  year: 1995
  end-page: 352
  ident: bib0160
  article-title: Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis
  publication-title: Am J Kidney Dis
  contributor:
    fullname: Suki
– volume: 46
  start-page: 1019
  year: 2002
  end-page: 1027
  ident: bib0030
  article-title: Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients
  publication-title: Arthritis Rheum
  contributor:
    fullname: Camps
– volume: 4
  start-page: 295
  year: 2006
  end-page: 306
  ident: bib0005
  article-title: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
  publication-title: J Thromb Haemost
  contributor:
    fullname: Cervera
– volume: 98
  start-page: 1760
  year: 2001
  end-page: 1764
  ident: bib0040
  article-title: Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study
  publication-title: Blood
  contributor:
    fullname: Nalçaci
– volume: 10
  start-page: 175
  year: 2001
  end-page: 181
  ident: bib0135
  article-title: Antiphospholipid antibody syndrome and renal disease
  publication-title: Curr Opin Nephrol Hypertens
  contributor:
    fullname: Appel
– volume: 20
  start-page: 206
  year: 2011
  end-page: 218
  ident: bib0020
  article-title: Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies
  publication-title: Lupus
  contributor:
    fullname: Derksen
– volume: 10
  start-page: 74
  year: 2010
  end-page: 79
  ident: bib0050
  article-title: Catastrophic antiphospholipid syndrome: updated diagnostic algorithms
  publication-title: Autoimmun Rev
  contributor:
    fullname: Cervera
– volume: 33
  start-page: 217
  year: 2012
  end-page: 222
  ident: bib0110
  article-title: Management of antiphospholipid syndrome
  publication-title: Rev Med Interne
  contributor:
    fullname: Costedoat-Chalumeau
– volume: 29
  start-page: 731
  year: 2008
  end-page: 734
  ident: bib0125
  article-title: The management of thrombosis in the antiphospholipid antibody syndrome: insights from recent clinical trials and remaining unsolved issues
  publication-title: Rev Med Interne
  contributor:
    fullname: Piette
– volume: 56
  start-page: 2382
  year: 2007
  end-page: 2391
  ident: bib0105
  article-title: Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals
  publication-title: Arthritis Rheum
  contributor:
    fullname: Sammaritano
– volume: 72
  start-page: 193
  year: 2009
  end-page: 198
  ident: bib0170
  article-title: Anticardiolipin antibodies in hemodialysis patients with hepatitis C and their role in fistula failure
  publication-title: Clin Nephrol
  contributor:
    fullname: Batun
– volume: 67
  start-page: 90
  year: 1999
  end-page: 93
  ident: bib0185
  article-title: Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients
  publication-title: Transplantation
  contributor:
    fullname: Racadot
– volume: 81
  start-page: 1239
  year: 2012
  end-page: 1244
  ident: bib0165
  article-title: IgA antibodies against β2 glycoprotein I in hemodialysis patients are an independent risk factor for mortality
  publication-title: Kidney Int
  contributor:
    fullname: Lora
– volume: 48
  start-page: 794
  year: 1995
  end-page: 800
  ident: bib0145
  article-title: Antiphospholipids in hemodialysis patients: relationship between lupus anticoagulant and thrombosis
  publication-title: Kidney Int
  contributor:
    fullname: Bernard
– volume: 8
  start-page: 168
  year: 2012
  end-page: 176
  ident: bib0055
  article-title: Renal biopsy practice: results of a French study and recommendations
  publication-title: Nephrol Ther
  contributor:
    fullname: Baumelou
– volume: 70
  start-page: 1083
  year: 2011
  end-page: 1086
  ident: bib0120
  article-title: Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study
  publication-title: Ann Rheum Dis
  contributor:
    fullname: Salvatore
– volume: 33
  start-page: 194
  year: 2012
  ident: 10.1016/j.nephro.2013.07.368_bib0060
  article-title: Catastrophic antiphospholipid syndrome
  publication-title: Rev Med Interne
  doi: 10.1016/j.revmed.2012.01.005
  contributor:
    fullname: Costedoat-Chalumeau
– volume: 13
  start-page: 42
  year: 2002
  ident: 10.1016/j.nephro.2013.07.368_bib0090
  article-title: Antiphospholipid syndrome nephropathy in systemic lupus erythematosus
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.V13142
  contributor:
    fullname: Daugas
– volume: 12
  start-page: 530
  year: 2003
  ident: 10.1016/j.nephro.2013.07.368_bib0045
  article-title: Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines
  publication-title: Lupus
  doi: 10.1191/0961203303lu394oa
  contributor:
    fullname: Asherson
– year: 2012
  ident: 10.1016/j.nephro.2013.07.368_bib0075
  contributor:
    fullname: Daugas
– volume: 68
  start-page: 397
  year: 2009
  ident: 10.1016/j.nephro.2013.07.368_bib0115
  article-title: Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2008.096669
  contributor:
    fullname: Ruffatti
– volume: 10
  start-page: 2051
  year: 2010
  ident: 10.1016/j.nephro.2013.07.368_bib0180
  article-title: Severe vascular lesions and poor functional outcome in kidney transplant recipients with lupus anticoagulant antibodies
  publication-title: Am J Transplant
  doi: 10.1111/j.1600-6143.2010.03233.x
  contributor:
    fullname: Canaud
– volume: 4
  start-page: 295
  year: 2006
  ident: 10.1016/j.nephro.2013.07.368_bib0005
  article-title: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
  publication-title: J Thromb Haemost
  doi: 10.1111/j.1538-7836.2006.01753.x
  contributor:
    fullname: Miyakis
– volume: 37
  start-page: 650
  year: 2005
  ident: 10.1016/j.nephro.2013.07.368_bib0175
  article-title: Management of end-stage renal disease patients with antiphospholipid antibody syndrome
  publication-title: Transplant Proc
  doi: 10.1016/j.transproceed.2004.12.151
  contributor:
    fullname: Vaidya
– volume: 26
  start-page: 347
  year: 1995
  ident: 10.1016/j.nephro.2013.07.368_bib0160
  article-title: Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis
  publication-title: Am J Kidney Dis
  doi: 10.1016/0272-6386(95)90656-8
  contributor:
    fullname: Prakash
– volume: 5
  start-page: 1211
  year: 2010
  ident: 10.1016/j.nephro.2013.07.368_bib0080
  article-title: Renal involvement in primary antiphospholipid syndrome: retrospective analysis of 160 patients
  publication-title: Clin J Am Soc Nephrol
  doi: 10.2215/CJN.00460110
  contributor:
    fullname: Sinico
– volume: 17
  start-page: 11
  year: 2008
  ident: 10.1016/j.nephro.2013.07.368_bib0100
  article-title: Influence of aspirin on the clinical outcomes of 103 antiphospholipid antibodies-positive patients
  publication-title: Lupus
  doi: 10.1177/0961203307084724
  contributor:
    fullname: Hereng
– volume: 8
  start-page: 168
  year: 2012
  ident: 10.1016/j.nephro.2013.07.368_bib0055
  article-title: Renal biopsy practice: results of a French study and recommendations
  publication-title: Nephrol Ther
  doi: 10.1016/j.nephro.2011.12.005
  contributor:
    fullname: Bollée
– volume: 18
  start-page: 2461
  year: 2007
  ident: 10.1016/j.nephro.2013.07.368_bib0095
  article-title: Antiphospholipid syndrome in systemic lupus erythematosus
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2007030257
  contributor:
    fullname: Hill
– volume: 98
  start-page: 1760
  year: 2001
  ident: 10.1016/j.nephro.2013.07.368_bib0040
  article-title: Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study
  publication-title: Blood
  doi: 10.1182/blood.V98.6.1760
  contributor:
    fullname: Diz-Küçükkaya
– volume: 46
  start-page: 1019
  year: 2002
  ident: 10.1016/j.nephro.2013.07.368_bib0030
  article-title: Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients
  publication-title: Arthritis Rheum
  doi: 10.1002/art.10187
  contributor:
    fullname: Cervera
– volume: 62
  start-page: 733
  year: 2002
  ident: 10.1016/j.nephro.2013.07.368_bib0010
  article-title: “Black swan in the kidney”: renal involvement in the antiphospholipid antibody syndrome
  publication-title: Kidney Int
  doi: 10.1046/j.1523-1755.2002.00500.x
  contributor:
    fullname: Nzerue
– volume: 13
  start-page: 1
  year: 2007
  ident: 10.1016/j.nephro.2013.07.368_bib0015
  article-title: Syndrome des antiphospholipides. Classification actuelle et indications thérapeutiques
  publication-title: Med Ther
  contributor:
    fullname: Wahl
– volume: 72
  start-page: 193
  year: 2009
  ident: 10.1016/j.nephro.2013.07.368_bib0170
  article-title: Anticardiolipin antibodies in hemodialysis patients with hepatitis C and their role in fistula failure
  publication-title: Clin Nephrol
  contributor:
    fullname: Ozmen
– volume: 9
  start-page: 26
  year: 2006
  ident: 10.1016/j.nephro.2013.07.368_bib0155
  article-title: Arteriovenous fistula thrombosis in patients on regular hemodialysis: a report of 171 patients
  publication-title: Arch Iran Med
  contributor:
    fullname: Roozbeh
– volume: 56
  start-page: 2382
  year: 2007
  ident: 10.1016/j.nephro.2013.07.368_bib0105
  article-title: Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals
  publication-title: Arthritis Rheum
  doi: 10.1002/art.22663
  contributor:
    fullname: Erkan
– volume: 25
  start-page: 3147
  year: 2010
  ident: 10.1016/j.nephro.2013.07.368_bib0070
  article-title: What nephrologists need to know about antiphospholipid syndrome
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gfq356
  contributor:
    fullname: Alchi
– volume: 10
  start-page: 507
  year: 1999
  ident: 10.1016/j.nephro.2013.07.368_bib0085
  article-title: The intrarenal vascular lesions associated with primary antiphospholipid syndrome
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.V103507
  contributor:
    fullname: Nochy
– volume: 29
  start-page: 731
  year: 2008
  ident: 10.1016/j.nephro.2013.07.368_bib0125
  article-title: The management of thrombosis in the antiphospholipid antibody syndrome: insights from recent clinical trials and remaining unsolved issues
  publication-title: Rev Med Interne
  doi: 10.1016/j.revmed.2008.05.013
  contributor:
    fullname: Wahl
– volume: 48
  start-page: 794
  year: 1995
  ident: 10.1016/j.nephro.2013.07.368_bib0145
  article-title: Antiphospholipids in hemodialysis patients: relationship between lupus anticoagulant and thrombosis
  publication-title: Kidney Int
  doi: 10.1038/ki.1995.352
  contributor:
    fullname: Brunet
– volume: 55
  start-page: 315
  year: 1999
  ident: 10.1016/j.nephro.2013.07.368_bib0150
  article-title: Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients
  publication-title: Kidney Int
  doi: 10.1046/j.1523-1755.1999.00258.x
  contributor:
    fullname: Manns
– volume: 118
  start-page: 4714
  year: 2011
  ident: 10.1016/j.nephro.2013.07.368_bib0025
  article-title: Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study
  publication-title: Blood
  doi: 10.1182/blood-2011-03-340232
  contributor:
    fullname: Pengo
– volume: 29
  start-page: 843
  year: 2002
  ident: 10.1016/j.nephro.2013.07.368_bib0065
  article-title: Perioperative medical management of antiphospholipid syndrome: hospital for special surgery experience, review of literature, and recommendations
  publication-title: J Rheumatol
  contributor:
    fullname: Erkan
– volume: 30
  start-page: 405
  year: 2009
  ident: 10.1016/j.nephro.2013.07.368_bib0130
  article-title: Antiphospholipid antibodies and renal involvement
  publication-title: Am J Nephrol
  doi: 10.1159/000235941
  contributor:
    fullname: Gigante
– volume: 7
  start-page: 1194
  year: 1992
  ident: 10.1016/j.nephro.2013.07.368_bib0140
  article-title: Are antiphospholipid antibodies clinically relevant in dialysis patients?
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/7.12.1194
  contributor:
    fullname: Chew
– volume: 10
  start-page: 175
  year: 2001
  ident: 10.1016/j.nephro.2013.07.368_bib0135
  article-title: Antiphospholipid antibody syndrome and renal disease
  publication-title: Curr Opin Nephrol Hypertens
  doi: 10.1097/00041552-200103000-00004
  contributor:
    fullname: Joseph
– volume: 70
  start-page: 1083
  year: 2011
  ident: 10.1016/j.nephro.2013.07.368_bib0120
  article-title: Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2010.142042
  contributor:
    fullname: Ruffatti
– volume: 67
  start-page: 90
  year: 1999
  ident: 10.1016/j.nephro.2013.07.368_bib0185
  article-title: Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients
  publication-title: Transplantation
  doi: 10.1097/00007890-199901150-00015
  contributor:
    fullname: Ducloux
– volume: 124
  start-page: 215
  year: 2011
  ident: 10.1016/j.nephro.2013.07.368_bib0035
  article-title: Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.111.028522
  contributor:
    fullname: Zuily
– volume: 10
  start-page: 74
  year: 2010
  ident: 10.1016/j.nephro.2013.07.368_bib0050
  article-title: Catastrophic antiphospholipid syndrome: updated diagnostic algorithms
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2010.08.005
  contributor:
    fullname: Erkan
– volume: 33
  start-page: 217
  year: 2012
  ident: 10.1016/j.nephro.2013.07.368_bib0110
  article-title: Management of antiphospholipid syndrome
  publication-title: Rev Med Interne
  doi: 10.1016/j.revmed.2012.01.007
  contributor:
    fullname: Saadoun
– volume: 81
  start-page: 1239
  year: 2012
  ident: 10.1016/j.nephro.2013.07.368_bib0165
  article-title: IgA antibodies against β2 glycoprotein I in hemodialysis patients are an independent risk factor for mortality
  publication-title: Kidney Int
  doi: 10.1038/ki.2011.477
  contributor:
    fullname: Serrano
– volume: 20
  start-page: 206
  year: 2011
  ident: 10.1016/j.nephro.2013.07.368_bib0020
  article-title: Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies
  publication-title: Lupus
  doi: 10.1177/0961203310395803
  contributor:
    fullname: Ruiz-Irastorza
SSID ssj0038411
Score 1.8768578
Snippet Le syndrome des antiphospholipides est une thrombophilie caractérisée par l’association d’un événement clinique thrombotique (artériel et/ou veineux) ou...
The antiphospholipid syndrome is a thrombophilia characterized by the combination of arterial and/or venous thrombotic events or obstetric clinical events,...
SourceID hal
crossref
pascalfrancis
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 1
SubjectTerms Anticoagulants
Antihypertensive Agents
Antiphospholipid Syndrome
Antiphospholipid syndrome nephropathy
Arterial Occlusive Diseases
Biopsy
Cardiovascular Diseases
Contraindications
Dialyse
Dialysis
Disease Management
Female
Humans
Kidney Diseases
Kidney Transplantation
Life Sciences
Middle Aged
Nephrologie. Maladies des voies urinaires
Nervous System Diseases
Néphropathie associée au syndrome des antiphospholipides
Platelet Aggregation Inhibitors
Renal Artery
Renal Circulation
Renal Dialysis
Renal Veins
Santé publique et épidémiologie
Sciences biologiques et medicales
Sciences medicales
Syndrome des antiphospholipides
Thrombocytopenia
Thrombophilia
Thrombosis
Thrombotic Microangiopathies
Traitement
Transplantation
Treatment
Title Le syndrome des antiphospholipides en néphrologie. Atteinte rénale et aspects pratiques de la prise en charge
URI https://dx.doi.org/10.1016/j.nephro.2013.07.368
https://hal.univ-lorraine.fr/hal-01791299
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fSxwxEB-8E0qhlFZbemqPUHxd7_aym-w-HlI5PfVBK_UtJNkET4695XbbR7-Pn8Mv5sz-EQVB8GFZNptMwi_DZIbMH4D9UAotwswHhvssiHCLgzQTNjBjj9ZCHFvPKcD57FzMrqKT6_h6Aw67WBhyq2xlfyPTa2ndtoxaNEfFYjG6xGlSOaECJaTmCt6DzfqSqA-b0-P57LwTyDyJ6jK81D-gAV0EXe3mlTsEjaIAQ05ZPDnlXH39hOrdkKvkp0KXiJ5vyl48O4uOvsDnVolk02adX2HDr7fgw1l7Tb4Nq1PHulQELHMlQ_gWxc2qxGe5oJqwJXM5yx_uaVUk_dwBm1ZU-LJybP1wj9QdcxXTdSBmyQriEzpBkBpbakbJEx2RqBMtuW9wdfT7z-EsaCsrBBbNo4TugWVojRyPfSS1TiKvQ-40506g-aYpaCSOXGxR_7MTG6UmTawzlIserTVhLf8O_XyVux_AjBFSei-1kAb_ZQbJGuF5mGU-9lk8gKBDUxVNAg3VeZbdqgZ9ReirsVSI_gBkB7l6wQgKZfwbI3_hDj1NQnmzZ9NTRW0kdlCxSf-HAxi-2MCn7pMEWUcmyc6759-Fj_gVNS7de9Cv1v_cT9RYKjOE3sFdOGz5kt7zi7_zRyMD7vI
link.rule.ids 230,315,783,787,888,4511,24130,27938,27939,45599,45693
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS-QwEB_8AD0QuQ-PWz29IPfa2-2mTdrHRU7qubsvKvgWkjTBlaVbtr37n_w7_Mduph-iIAg-9CVNJuGXYTIhM78B-BlKoUWY-8BwnwcRbnGQ5sIGZuTxthDH1nNKcJ7NRXYT_bmNbzfgrM-FobDKzva3Nr2x1l3LsENzWC4WwyucJpVjKlBCbq7gm7CN3kCKyr49ubjM5r1B5knUlOGl_gEN6DPomjCvwiFolAUYcmLx5MS5-voJtXlHoZJ7pa4QPd-WvXh2Fp1_hP3OiWSTdp2fYMOvP8POrHsm_wKrqWM9FQHLXcUQvkV5t6rwWy6oJmzFXMGKxwdaFVk_94tNaip8WTu2fnxA6Y65mukmEbNiJekJnSAojS01I_JERyIaoiV3ADfnv6_PsqCrrBBYvB4l9A4sQ2vkaOQjqXUSeR1ypzl3Aq9vmpJG4sjFFv0_O7ZRatLEOkNc9HhbE9byr7BVrAr3DZgxQkrvpRbS4L_coFgjPA_z3Mc-jwcQ9GiqsiXQUH1k2b1q0VeEvhpJhegPQPaQqxeKoNDGvzHyFHfoaRLizc4mU0VtZHbQsUn_hQM4ebGBT93HCeqRTJLDd8__A3az69lUTS_ml0fwAf9EbXj3d9iq13_dMXovtTnptPM_iSbvTA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Le+syndrome+des+antiphospholipides+en+n%C3%A9phrologie.+Atteinte+r%C3%A9nale+et+aspects+pratiques+de+la+prise+en+charge&rft.jtitle=N%C3%A9phrologie+%26+th%C3%A9rapeutique&rft.au=DEKEYSER%2C+Manon&rft.au=ZUILY%2C+St%C3%A9phane&rft.au=CHAMPIGNEULLE%2C+Jacqueline&rft.au=ESCHWEGE%2C+Val%C3%A9rie&rft.date=2014-02-01&rft.pub=Elsevier+Masson&rft.issn=1769-7255&rft.eissn=1872-9177&rft.volume=10&rft.issue=1&rft.spage=1&rft.epage=9&rft_id=info:doi/10.1016%2Fj.nephro.2013.07.368&rft.externalDBID=n%2Fa&rft.externalDocID=28130788
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1769-7255&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1769-7255&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1769-7255&client=summon